News Releases

NASDAQ, TSX: NVCN VANCOUVER, March 23, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX:NVCN) announced today that it has received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") ...

NASDAQ, TSX: NVCN VANCOUVER, March 21, 2018 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced that it ...

NASDAQ, TSX: NVCN VANCOUVER, Feb. 12, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that Fred Colen, President and Chief Executive Officer of Neovasc, is scheduled to present at the LEERINK Partners ...

Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure NASDAQ, TSX: NVCN VANCOUVER, Feb. 1, 2018 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of ...

Recognized Multinational Senior Executive Poised to Drive Commercialization and Clinical Advances NASDAQ, TSX: NVCN VANCOUVER, Jan. 22, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (Nasdaq, TSX: NVCN), a front-runner in minimally ...

NASDAQ, TSX: NVCN VANCOUVER, Jan. 18, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (Nasdaq, TSX: NVCN) today reported its Neovasc Reducer™ ("Reducer") was featured in a "live case" broadcast to more than 800 participants at ...

- 10 new implants performed in the past 60 days -  NASDAQ, TSX: NVCN VANCOUVER, Jan. 8, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today provided an update on its clinical program for the Tiara™ ("Tiara") valve, ...

VANCOUVER, Jan. 2, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX:NVCN) announced today that it has received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company ...

- Clinical updates for both Reducer™ and Tiara™ also presented at premier event - NASDAQ, TSX: NVCN VANCOUVER, Dec. 6, 2017 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today reported its Neovasc Reducer™ ("Reducer") ...

NASDAQ, TSX: NVCN VANCOUVER, Nov. 27, 2017 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that Chris Clark, chief financial officer, is scheduled to present at the 29th Annual Piper Jaffray ...